This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Endourology
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • AMA Interim 2023
      • SUO 2023
      • ESMO 2023
      • IBCN 2023
      • ASTRO 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Prospective study on metabolic factors and risk of prostate cancer - Abstract November 20, 2012
Androgen metabolism gene polymorphisms, associations with prostate cancer risk and pathological characteristics: A comparative analysis between South African and Senegalese men - Abstract November 20, 2012
Association of obesity and diabetes with serum prostate-specific antigen levels in Japanese males - Abstract November 20, 2012
The REDUCE metagram: A comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer - Abstract November 19, 2012
Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer - Abstract November 19, 2012
Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy - Abstract November 19, 2012
Complications of laparoscopic radical prostatectomy-a single institute experience - Abstract November 19, 2012
Strength training induces muscle hypertrophy and functional gains in Black prostate cancer patients despite androgen deprivation therapy - Abstract November 19, 2012
Cabazitaxel: More than a new taxane for metastatic castrate-resistant prostate cancer? - Abstract November 19, 2012
Management of docetaxel failures in metastatic castrate-resistant prostate cancer - Abstract November 16, 2012
Targeted therapies in metastatic castration-resistant prostate cancer: Beyond the androgen receptor - Abstract November 16, 2012
Bone-targeted agents: Preventing skeletal complications in prostate cancer - Abstract November 16, 2012
Advanced clinical states in prostate cancer - Abstract November 16, 2012
The experience with cytotoxic chemotherapy in metastatic castration-resistant prostate cancer - Abstract November 16, 2012
Pathological features of lymph node metastases in predicting biochemical recurrence after radical prostatectomy for prostate cancer - Abstract November 16, 2012
The trifecta outcome in 300 consecutive cases of robotic-assisted laparoscopic radical prostatectomy according to D'Amico risk criteria - Abstract November 16, 2012
MAPPED study design: A 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging - Abstract November 16, 2012
Changes in quality of life among prostate cancer patients after surgery - Abstract November 16, 2012
Biology of castration-recurrent prostate cancer - Abstract November 15, 2012
Immunotherapy for castration-resistant prostate cancer - Abstract November 15, 2012
Page 1135 of 1351
  • Start
  • Prev
  • 1130
  • 1131
  • 1132
  • 1133
  • 1134
  • 1135
  • 1136
  • 1137
  • 1138
  • 1139
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free